High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy

Por Kalathil, Suresh Gopi, Thanavala, Yasmin
Publicado no Cancer Immunol Immunother (2016)

Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease

Por Bhat, Tariq A., Panzica, Louis, Kalathil, Suresh Gopi, Thanavala, Yasmin
Publicado no Ann Am Thorac Soc (2015)

Higher frequencies of GARP+ CTLA-4+ Foxp3+ T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T cell function...

Por Kalathil, Suresh, Lugade, Amit A, Miller, Austin, Iyer, Renuka, Thanavala, Yasmin
Publicado em 2013

High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?

Por Lugade, Amit A, Kalathil, Suresh, Miller, Austin, Iyer, Renuka, Thanavala, Yasmin
Publicado em 2013

Augmentation of IFN-γ(+) CD8(+) T cell responses correlates with survival of HCC patients on sorafenib therapy

Por Kalathil, Suresh Gopi, Hutson, Alan, Barbi, Joseph, Iyer, Renuka, Thanavala, Yasmin
Publicado no JCI Insight (2019)

Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients

Por Kalathil, Suresh Gopi, Wang, Katy, Hutson, Alan, Iyer, Renuka, Thanavala, Yasmin
Publicado no Oncoimmunology (2020)

PD-1(+) and Foxp3(+) T cell reduction correlates with survival of HCC patients after sorafenib therapy

Por Kalathil, Suresh Gopi, Lugade, Amit Anand, Miller, Austin, Iyer, Renuka, Thanavala, Yasmin
Publicado no JCI Insight (2016)

Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib

Por Kalathil, Suresh Gopi, Lugade, Amit Anand, Iyer, Renuka, Miller, Austin, Thanavala, Yasmin
Publicado no Oncoimmunology (2016)

Specialized pro-resolving mediators overcome immune suppression induced by exposure to secondhand smoke

Por Bhat, Tariq A., Kalathil, Suresh Gopi, Miller, Austin, Thatcher, Thomas H., Sime, Patricia J., Thanavala, Yasmin
Publicado no J Immunol (2020)

T-Regulatory Cells and Programmed Death 1(+) T Cells Contribute to Effector T-Cell Dysfunction in Patients with Chronic Obstructive Pulmonary Disease

Por Kalathil, Suresh Gopi, Lugade, Amit Anand, Pradhan, Vandana, Miller, Austin, Parameswaran, Ganapathi Iyer, Sethi, Sanjay, Thanavala, Yasmin
Publicado no Am J Respir Crit Care Med (2014)

An Animal Model of Inhaled Vitamin E Acetate and EVALI-like Lung Injury

Por Bhat, Tariq A., Kalathil, Suresh G., Bogner, Paul N., Blount, Benjamin C., Goniewicz, Maciej L., Thanavala, Yasmin M.
Publicado no N Engl J Med (2020)

AT-RvD1 mitigates SHS-exacerbated pulmonary inflammation and restores SHS-suppressed anti-bacterial immunity

Por Bhat, Tariq A., Kalathil, Suresh Gopi, Bogner, Paul N, Lehmann, Paul V., Thatcher, Thomas H., Sime, Patricia J., Thanavala, Yasmin
Publicado no J Immunol (2021)

Secondhand smoke induces inflammation and impairs immunity to respiratory infections

Por Bhat, Tariq A., Kalathil, Suresh Gopi, Bogner, Paul N., Miller, Austin, Lehmann, Paul V, Thatcher, Thomas H., Phipps, Richard P., Sime, Patricia J., Thanavala, Yasmin
Publicado no J Immunol (2018)